Abstract:Objective: The protein arginine methyltransferase 5 (PRMT5) catalyzes the symmetrical bimethylation of arginine residues, which plays an important regulatory role in the life process. Transcription factor c-Myc is widely proved involved in the alteration and development of tumors, while the regulatory mechanism of c-Myc-mediated gene expression has not been fully understood. In this article we try to investigate the functional role of PRMT5 and c-Myc in regulating multiple myeloma cell proliferation. Methods: The protein and mRNA expression levels of PRMT5 in myeloma cells and normal cells were detected by Western Blot and qPCR. Lentivirally transduced shRNAs targeting PRMT5 (sh-PRMT5) was constructed using lentivirus mediated RNAi technology, and was packaged to infect MM cells to select positive colonies. The effect of PRMT5 on the proliferation of MM cells was detected by cck-8 assay. Annexin V/7-AAD double staining flow cytometry was used to detect cell survival and apoptosis rate. The expression of apoptotic suppressor gene c-Myc in sh-PRMT5 cell lines was detected by Western Blot and qPCR. Finally, double-knockdown of PRMT5 and c-myc was performed and gene expression differentiation were identified by RNA sequencing (RNA-seq). Results: PRMT5 expression in MM cell lines (RPMI8226 and U266) was relatively high compared with peripheral blood mononuclear cells (PBMCs), which was correlated with progression-free survival (PFS) and overall survival (OS) in MM patients. After sh-PRMT5 infection to MM cell lines, puromycin selection was performed and efficient gene knockdown was evaluated by Western Blot and qPCR. After targeted silencing of PRMT5 expression, the proliferation of MM cells was decreased and apoptosis was significantly increased (P < 0.05). C-Myc protein and mRNA levels were significantly downregulated after PRMT5 gene silencing. The results showed that PRMT5 promoted the proliferation of MM cells and inhibited the apoptosis of MM cells by regulating the expression of apoptotic suppressor gene c-Myc. Subsequently, RNA-seq confirmed SMCHD1 as the common candidate target gene of c-myc and PRMT5. Therefore, we speculated that PRMT5 and c-Myc may jointly regulate TNRC6B gene to promote the proliferation of MM cells. Conclusion: Altogether, our study not only proposed the mechanism PRMT5 and c-myc in regulating multiple myeloma related gene expression, but also provided a new strategy and theoretical basis for clinical treatment of multiple myeloma. Disclosures No relevant conflicts of interest to declare.

c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle

C-Myc is Regulated by HIF-2α in Chronic Hypoxia and Influences Sensitivity to 5-FU in Colon Cancer.

C-Myc-induced Chemosensitization is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-Kappa B Activity in Pancreatic Cancer Cells.

Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.

The Requirement for Cyclin E in C-Myc Overexpressing Breast Cancers.

C-Myc Promotes Tumor Proliferation and Anti-Apoptosis by Repressing P21 in Rhabdomyosarcomas

Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis

CRL2 KLHDC3 and CRL1 Fbxw7 cooperatively mediate c-Myc degradation

Role of Myc in Hepatocellular Proliferation and Hepatocarcinogenesis.

MYC Oncogene Contributions to Release of Cell Cycle Brakes

MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1∼let-7d Via Noncanonical E-box

RNAi Silencing of C-Myc Inhibits Cell Migration, Invasion, and Proliferation in HepG2 Human Hepatocellular Carcinoma Cell Line: C-Myc Silencing in Hepatocellular Carcinoma Cell

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

Prevention of Cell Proliferation Signaling Via RNA Interference of c-myc Gene Expression in Colon Cancer In-vitro

Ribosomal Protein S14 Negatively Regulates c-Myc Activity

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response

MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation

C-Myc Promotes Cholangiocarcinoma Cells to Overcome Contact Inhibition Via the Mtor Pathway

Myc inhibition tips the immune balance to promote antitumor immunity

Myc inhibition impairs autophagosome formation

C-Myc-Driven and PRMT5-Dependent Regulation of Multiple Myeloma Cell Proliferation Through TNRC6B Gene